Dupilumab-related late adverse events in patients with chronic rhinosinusitis with nasal polyps. Matsuyama T, Sakurai M, Chikamatsu K. Acta Otolaryngol 2024;144:570-573.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Matsuyama T, Sakurai M, Chikamatsu K. Dupilumab-related late adverse events in patients with chronic rhinosinusitis with nasal polyps. Acta Otolaryngol 2024;144:570-573.
PMID: 39363662